Previous work in humans reported increased aromatase gene and protein expression in female placentae from preeclamptic pregnancies when compared with males [49], which the authors concluded may be a sexually dimorphic response to protect the female fetus from virilization associated with increased maternal androgen concentrations associated with preeclampsia. The gene discussed is CYP19A1; the disease is preeclampsia.